|
시장보고서
상품코드
2052837
비침습적 혈당 측정 기기 시장 : 기술별, 측정 방식별, 최종사용자별, 지역별Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, By Modality, By End User, By Geography |
||||||
비침습적 혈당 측정 기기 시장은 2026년에 2,820만 달러로 추정되며, 2033년까지 8,020만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 16.1%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 2,820만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 16.10% | 2033년 시장 규모 예측: | 8,020만 달러 |
비침습적 혈당 측정은 이름에서 알 수 있듯이 인체 조직에 손상을 입히지 않고 사람의 혈당치를 측정하는 것을 말합니다. 비침습적 혈당 측정 기기는 기존의 손가락 끝 천자법에 비해 경제적이고 통증 없는 혈당 측정 방법을 제공합니다. 이 장비는 채혈을 하는 대신 피부 근처의 혈관을 스캔하는 방식으로 작동합니다. 최소침습 마이크로니들, 근적외선 분광법, 초광대역 레이더 등 혈당 센싱 기술의 발전으로 침습적 모니터링 방법에 의한 측정값에 매우 근접한 결과를 얻을 수 있는 비침습적 제품 개발이 가능해졌습니다. 이를 통해 당뇨병 환자들은 자신의 질환 관리에 있어 보다 높은 편의성과 순응도를 얻을 수 있습니다. 비침습적 혈당 측정 기기는 기술에 따라 전자파, 경피, 광학, 효소, 전자기파, 경피, 광학, 효소 등으로 분류할 수 있습니다.
시장 역학
비침습적 혈당 측정 기기 시장은 전 세계 당뇨병 환자 수 증가와 더불어 연속 혈당 모니터링 기술의 발전에 힘입어 성장하고 있습니다. 손가락 끝 천자 등 기존 침습적 검사법의 문제점을 극복할 수 있는 혁신적인 솔루션을 가지고 많은 신규 업체들이 시장에 진입하고 있습니다. 그러나 기준법 대비 정확도 향상에 대한 기술적 제약, 임상적 검증 부족, 규제 당국의 승인 지연 등의 요인이 여전히 보급을 가로막고 있는 실정입니다. 그럼에도 불구하고, 알고리즘과 센서 개선에 초점을 맞춘 지속적인 연구 개발은 비침습적 솔루션이 기존의 혈당 검사를 대체할 수 있는 실용적인 대안이 될 수 있는 유망한 기회를 창출하고 있습니다.
지식 부족과 진단 지연은 예측 기간 동안 세계 비침습적 혈당 측정 기기 시장의 성장을 저해할 것으로 예상됩니다.
본 조사의 주요 특징
- 이 조사에서는 각 부문의 잠재적인 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 이 보고서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 세계 비침습적 혈당 측정 기기 시장의 주요 기업 프로파일을 회사 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략과 같은 매개 변수를 기반으로 작성되었습니다.
- 이 조사에서 다루는 주요 기업으로는 Baxter International Inc., Dexcom, Inc, Abbott, Medtronic, Senseonics Holdings, Inc, GlySens Incorporated, DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, RSP Systems A/S 등이 포함됩니다.
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 모델 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 세계 비침습적 혈당 측정 장치 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 비침습적 혈당 측정 기기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 비침습적 혈당 측정 기기 시장 : 기술별, 2021-2033년
제5장 세계의 비침습적 혈당 측정 기기 시장 : 모달리티별, 2021-2033년
제6장 세계의 비침습적 혈당 측정 기기 시장 : 최종사용자별, 2021-2033년
제7장 세계의 비침습적 혈당 측정 기기 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.06.17Non-Invasive Blood Glucose Monitoring Devices Market is estimated to be valued at USD 28.2 Mn in 2026 and is expected to reach USD 80.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 16.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 28.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 16.10% | 2033 Value Projection: | USD 80.2 Mn |
Non-invasive blood glucose monitoring, as its name implies, refers to the detection of human blood glucose without causing damage to human tissues. Non-invasive blood glucose monitoring devices offer an economical and pain-free method to monitor blood glucose levels compared to traditional finger-pricking methods. These devices work by scanning the blood vessels near the skin instead of drawing blood. Advancement in glucose sensing technologies, such as minimally-invasive micro needles, near infrared spectroscopy, and ultra wideband radar, have facilitated the development of non-invasive products that can closely mirror readings from invasive monitoring methods. This provides diabetics with greater convenience and compliance in managing their condition. Non-invasive blood glucose monitoring devices can be segmented on the basis of technology into EM waves, transdermal, optical, and enzymatic.
Market Dynamics
The non-invasive blood glucose monitoring devices market is driven by the growing prevalence of diabetes worldwide as well as advancements in continuous glucose monitoring technologies. Many new players are entering the market with novel solutions that can help overcome the challenges with existing invasive methods like finger pricks. However, factors such as technical limitations in achieving high accuracy compared to reference methods, insufficient clinical validation, and slow regulatory approvals continue to restrain widespread adoption. Nonetheless, continued R&D focusing on improved algorithms and sensors offers promising opportunities for non-invasive solutions to become a viable alternative to conventional glucose tests.
Lack of knowledge and diagnosis are expected to hamper the growth of the global non-invasive blood glucose monitoring devices market over the forecast period.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global non-invasive blood glucose monitoring devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Baxter International Inc., Dexcom, Inc, Abbott, Medtronic, Senseonics Holdings, Inc, GlySens Incorporated, DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global non-invasive blood glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non-invasive blood glucose monitoring devices market
Market Segmentation
- Technology Insights (Revenue, USD Mn, 2021 - 2033)
- EM Waves
- Transdermal
- Optical
- Enzymatic
- Modality Insights (Revenue, USD Mn, 2021 - 2033)
- Wearable
- Non-wearable/Benchtop
- Embedded Devices
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Clinics
- Homecare setting
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Baxter International Inc.
- Dexcom, Inc.
- Abbott Laboratories
- Medtronic Plc
- Senseonics Holdings, Inc.
- GlySens Incorporated
- DiaMonTech GmbH
- Nemaura Medical Inc.
- Integrity Applications, Inc.
- CNOGA Medical Ltd.
- Breath Health, Inc.
- Metamaterial Technologies Inc.
- Opticology Inc.
- NovioSense BV
- Quick LLC
- RSP Systems A/S
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Modality
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rising prevalence of diseases like myasthenia gravis and postoperative ileus requiring neostigmine
- Restraints
- Lack of knowledge and diagnosis
- Opportunities
- The growth of veterinary medicine
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- EM Waves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Optical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Enzymatic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
5. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Modality, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Wearable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Non-wearable/Benchtop
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Embedded Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Global Non-Invasive Blood Glucose Monitoring Devices Market, By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Homecare setting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
7. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub Region, 2021 - 2033,(US$ Mn)
- GCC
- Israel
- Rest of Middle East
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dexcom, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Senseonics Holdings, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlySens Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- DiaMonTech GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nemaura Medical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Integrity Applications, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CNOGA Medical Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Breath Health, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Metamaterial Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Opticology Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NovioSense BV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quick LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- RSP Systems A/S.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
